Used as a key intermediate in the synthesis of fluoroquinolone antibiotics, this compound plays an important role in pharmaceutical development. Its structure supports the formation of potent antimicrobial agents that target DNA gyrase and topoisomerase IV in bacteria. It is particularly valuable in creating derivatives with enhanced activity against resistant strains. Additionally, it serves in research for developing new quinolone-based drugs with improved pharmacokinetics and reduced side effects.